Global Transplant Diagnostics Market report published by Accurize Market Research forecast that the global market is expected to reach $5 billion by 2025; growing at a CAGR of 7.5% from 2017 to 2025. By geography, the Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.

Request Sample:
https://www.accurizemarketresearch.com/report/transplant-diagnostics-market/sample-request

The increasing number of organ transplant procedures to drive the global market

Major driving factors for this market are raising the incidence of chronic diseases, increasing aged population, number of organ transplant procedures, technological advancements, and increased R&D activities. However, lack of awareness and organ shortage for transplant procedures are witnessing the growth of the market. The increasing need for organ transplants and the growing burden of chronic diseases in emerging nations are creating future opportunities for the transplant diagnostics market.

Market Segmentation

The transplant diagnostics market is segmented into end-user, technology, organ type, application, screening type, and geography. On the basis of end-user, the transplant diagnostics market is segmented into research laboratories and academic institutions, hospitals and transplant centers and commercial service providers. By organ type, the market is segmented into liver, kidney, heart, pancreas, lung, and others. On the basis of technology, transplant diagnostics market is segmented into the molecular assay, non-molecular assay, and sequencing-based. Furthermore, by screening type, the market is segmented into pre-transplant Screening and post-transplant Screening. On the basis of application, this market is segmented into research applications and diagnostic applications.

North America, Europe, Asia-Pacific and Rest of the world (RoW) are the geographical segments of the market. North America is further bifurcated into countries namely; U.S., Canada, and Mexico. Europe covers countries like Russia, the U.K., Germany, France, Italy and Rest of Europe. Asia-Pacific countries include China, India, Japan, South Korea and Rest of Asia Pacific. Rest of the World (RoW) covers South America, Africa, and the Middle East.

Customize Report:
https://www.accurizemarketresearch.com/report/transplant-diagnostics-market/ask-for-customization

"Reagents & consumables accounted for the largest market share in the product segment", says Accurize

In the product segment, reagents & consumables segment is expected to account for the largest share of the global transplant diagnostics market in 2017. Factors such as the increasing patient emphasis on effective and early patient profiling during organ transplantation and the growing adoption of transplant diagnostic techniques in related research studies are driving the growth of this segment. The molecular assay technology segment is expected to register the highest CAGR during the forecast period. Solid-organ transplantation is expected to account for the largest share of the transplant diagnostics market in 2017.

"North America dominated the global market with the highest market share over the forecast period", says Accurize

The large share of North America can be attributed to the continuous commercialization of innovative transplant diagnostic products coupled with ongoing advancements in the field of genomics and proteomics, recent discovery genetic biomarkers & their clinical role in immunoassay testing, and increasing prevalence of chronic and communicable diseases.

Top players in the market

Major companies operating in the market include Thermo Fisher Scientific Inc., Bio- F. Hoffmann-La Roche, Ltd., Sigma-Aldrich, Abbott Laboratories Inc., Qiagen N.V., Illumina, Inc., Linkage Biosciences, Immucor Inc., OlerupSspAb, and Rad Laboratories Inc. including others.